1.24 USD
↘ 0.06 (4.62%)AT CLOSE (03:59 PM EST)
Alzamend Neuro, Inc. Common Stock
ALZNNASDAQ • USD
1.26
↗ 0.02 (1.37%)
POST MARKET (AS OF 07:56 PM EST)
Post Market
AS OF 07:56 PM EST
1.26
↗ 0.02 (1.37%)
Market: CLOSED
ALZN is currently priced at $1.25. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, ALZN appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Nov 13, 2026.
Open?$1.34
High?$1.38
Low?$1.23
Prev. Close?$1.30
Volume?38.8K
Avg. Volume?39.1K
VWAP?$1.31
Rel. Volume?0.99x
Bid / Ask
Bid?$1.18 × 500
Ask?$1.33 × 2.0K
Spread?$0.15
Midpoint?$1.26
Valuation & Ratios
Market Cap?6.3M
Shares Out?4.8M
Float?4.8M
Float %?98.6%
P/E Ratio?N/A
P/B Ratio?1.08
EPS?-$1.89
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's disease. The Company has two therapeutic drug candidates, AL001 and ALZN002. Its pipeline consists of AL001, a patented ionic cocrystal technology delivering lithium through a therapeutic combination of lithium, proline and salicylate; and ALZN002, a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's disease.
Address
480 PEACHTREE ROAD NE, SECOND FLOOR
ATLANTA, GA 30326
Phone: 844-722-6333
ATLANTA, GA 30326
Phone: 844-722-6333
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?100
Piotroski F-Score?0/9Weak
Altman Z-Score?-12.89Distress
Confidence?43%Low
Short InterestLow
Short % of Float?0.37%Low
Short Interest?17.6K
Days to Cover?1.1
Free Float4.8M
Avg Daily Volume16.7K
Settlement Date2026-10-30
Financial Health
Current Ratio?3.01Strong
Quick Ratio?3.01Strong
Cash Ratio?2.77Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.08CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.2CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-156.8%WEAK▾
S&P3
ROA?-106.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-6843544
Enterprise Value?$-1318004
Fundamentals ratios updated end of day